GLP-1 Receptor Agonists and the Reduction of Alcohol-Related Hospitalizations in Alcohol Use Disorder

from TheBrief.Health · host TheBrief.Health

New real-world evidence suggests semaglutide and tirzepatide may reduce alcohol-related hospitalizations among patients with AUD and metabolic disease, warranting further clinical trials.

Episode metadata supplied by the publisher feed · Published Aug 12, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

GLP-1 Receptor Agonists and the Reduction of Alcohol-Related Hospitalizations in Alcohol Use Disorder

0:00 1:19

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on August 12, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!